Paroxetine for self-injurious behavior. 1994

R W Snead, and F Boon, and J Presberg

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001321 Autistic Disorder A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome
D016728 Self-Injurious Behavior Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation. Intentional Self Harm,Intentional Self Injury,Self Harm,Self-Destructive Behavior,Deliberate Self-Harm,Non-Suicidal Self Injury,Nonsuicidal Self Injury,Self-Injury,Behavior, Self-Destructive,Behavior, Self-Injurious,Deliberate Self Harm,Harm, Self,Intentional Self Injuries,Non Suicidal Self Injury,Non-Suicidal Self Injuries,Nonsuicidal Self Injuries,Self Destructive Behavior,Self Harm, Intentional,Self Injurious Behavior,Self Injury,Self Injury, Intentional,Self Injury, Non-Suicidal,Self Injury, Nonsuicidal,Self-Destructive Behaviors,Self-Harm, Deliberate,Self-Injurious Behaviors
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017374 Paroxetine A serotonin uptake inhibitor that is effective in the treatment of depression. Aropax,BRL-29060,FG-7051,Paroxetine Acetate,Paroxetine Hydrochloride,Paroxetine Hydrochloride Anhydrous,Paroxetine Hydrochloride Hemihydrate,Paroxetine Hydrochloride, Hemihydrate,Paroxetine Maleate,Paroxetine, cis-(+)-Isomer,Paroxetine, cis-(-)-Isomer,Paroxetine, trans-(+)-Isomer,Paxil,Seroxat,BRL 29060,BRL29060,FG 7051,FG7051

Related Publications

R W Snead, and F Boon, and J Presberg
November 2004, Journal of the American Academy of Child and Adolescent Psychiatry,
R W Snead, and F Boon, and J Presberg
January 2018, Neuroscience and biobehavioral reviews,
R W Snead, and F Boon, and J Presberg
March 1992, The American journal of psychiatry,
R W Snead, and F Boon, and J Presberg
September 2005, MMW Fortschritte der Medizin,
R W Snead, and F Boon, and J Presberg
January 1990, Progress in neuro-psychopharmacology & biological psychiatry,
R W Snead, and F Boon, and J Presberg
May 1983, The American journal of psychiatry,
R W Snead, and F Boon, and J Presberg
January 1983, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry,
R W Snead, and F Boon, and J Presberg
April 1993, The American journal of clinical hypnosis,
R W Snead, and F Boon, and J Presberg
January 1996, Journal of applied behavior analysis,
R W Snead, and F Boon, and J Presberg
October 1987, Annals of neurology,
Copied contents to your clipboard!